The independent source for health policy research, polling, and news.
1,341-1,360 of 113,144 results
The North Carolina State Health Plan is rolling out to more than 700,000 teachers, state workers, and their families. The unusual approach is an effort to save the state money on health care in the long run. Plus, news from New Hampshire, Colorado, Illinois, Florida, and elsewhere.
State lawmakers had tried to prevent national chains from moving in and replacing local physicians, but nonprofit PeaceHealth tapped an Atlanta-based company to staff its Oregon emergency rooms, STAT reports. Doctors, lawmakers, and others are pushing back on that decision.
The potential partnership comes a month after Novo sued Hims over obesity drug knockoffs. Also: A new study finds that generic versions of Ozempic and Wegovy could be sold for less than $3 a month.
Industry leaders and academics are concerned that decision-making input from agency leaders, drug developers, patients, and physicians has largely been cast aside during the Trump administration. Plus, Democrats are going to drugmakers directly for information about Trump's drug deals.
Prasad, who has been embroiled in recent controversial decisions at the Food and Drug Administration, will leave in late April. Separately, surgeon general nominee Casey Means is facing opposition on multiple fronts. Also, 11 more children have died from flu-related complications.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
The bill would set new requirements for parental controls and require certain online platforms to put policies in place to address certain harms to kids online, Roll Call reported.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on FDA denials, cashless bail, mental health, and more.
Over six weeks ago, a major sewage line collapsed, sending 243 million gallons of sewage into the river. Despite health authorities stating it is now safe to get back into the water, citizens remain skeptical. Plus, news from Maryland, Minnesota, West Virginia, Georgia, New York, and elsewhere.
FDA and HHS officials have publicly attacked Uniqure, the biotech company seeking approval for a Huntington’s disease treatment, and accused it of lying about requests made by the FDA for additional studies involving placebo brain surgery, which the company has characterized as unethical. The company says the anonymous FDA statements "are incomplete or entirely incorrect.”
Missouri-based Freeman Health System has agreed to buy the hospitals, along with outpatient centers and physician practices, allowing it to expand its reach into neighboring Arkansas. Plus, Amazon Web Services, CVS Health, and Salesforce move forward with AI health tools.
The look at New York's program comes a week after the Trump administration froze nearly $260 million of Minnesota's Medicaid funding. Also in the news: the impact of the Medicaid work mandate on homeless Californians; the rate of Tylenol use by pregnant women in ERs after President Donald Trump's September autism comments; and more.
According to two people who spoke to The Washington Post on condition of anonymity, President Trump told advisers that he had grown increasingly unhappy with Kristi Noem after the surge of thousands of immigration enforcement officers in Minnesota in December and January, an escalation that led to the fatal shootings of Renee Good and Alex Pretti, an ICU nurse at the VA.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
In recent years, at least eight states have given funds, meant to help families experiencing poverty, to crisis pregnancy centers. As many as $2 of every $3 for pregnancy centers in Missouri is expected to come from the federal Temporary Assistance for Needy Families program in the 2026 fiscal year.
Opinion writers delve into these public health topics.
STAT reports that administration officials have declined to offer details on the number of new drugs expected to be added, when that might happen, or how many people have used the site.
Meanwhile, Eli Lilly has launched an Employer Contract, its direct-to-employer platform for GLP-1s. Plus, researchers find that most patients can keep the weight off with less frequent GLP-1 shots.
© 2026 KFF